NCT00873769View on ClinicalTrials.gov

Staccato Loxapine PK in Smokers and Nonsmokers

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Smoking, Cigarette
Interventions
DRUG

Inhaled Loxapine 10 mg

Staccato Loxapine 10 mg, single dose

Trial Locations (1)

47710

Covance Clinical Research Unit, Inc., Evansville

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY